GO
Loading...

Cramer Backs Alexion Stock

Friday, 6 Jan 2012 | 7:47 PM ET
Cramer's Super Bowl Stocks: ALXN vs. COG
Mad Money's Cramer pits S&P favorite, Cabot Oil and Gas, against NASDAQ winner, Alexion, to see which company brings home the "Best Stock" trophy.

All this week, Cramer compared the strongest performers of both the S&P 500 and Nasdaq and on Friday, he decided that Alexion Pharmaceuticals is the best of the bunch.

Based in Cheshire, Conn., Alexion is a biopharmaceutical company that engages in the discovery and development of biological therapeutic products for treating patients with severe and life-threatening diseases. Cramer likes its stock for many reasons, such as it has a low PEG ratio, a metric that relates growth rate to valuation. Alexion is currently trading at 1.2 times growth.

Alexion is also a prime takeover candidate, especially as big pharma companies have been hungry to snap up these kind of orphan drug developers. The company has a lot of potential, too, because its main drug could be approved for multiple new indications.

So Cramer recommends investors consider ALXN at current levels.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change
ALXN
---

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.